X-117898954-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001168302.2(KLHL13):āc.1874A>Gā(p.Glu625Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000117 in 1,209,020 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 41 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000098 ( 0 hom., 1 hem., cov: 23)
Exomes š: 0.00012 ( 0 hom. 40 hem. )
Consequence
KLHL13
NM_001168302.2 missense
NM_001168302.2 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 5.78
Genes affected
KLHL13 (HGNC:22931): (kelch like family member 13) This gene encodes a BTB and kelch domain containing protein and belongs to the kelch repeat domain containing superfamily of proteins. The encoded protein functions as an adaptor protein that complexes with Cullin 3 and other proteins to form the Cullin 3-based E3 ubiquitin-protein ligase complex. This complex is necessary for proper chromosome segregation and completion of cytokinesis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.049581915).
BS2
High Hemizygotes in GnomAdExome4 at 40 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLHL13 | NM_001168302.2 | c.1874A>G | p.Glu625Gly | missense_variant | 8/8 | ENST00000540167.6 | NP_001161774.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLHL13 | ENST00000540167.6 | c.1874A>G | p.Glu625Gly | missense_variant | 8/8 | 2 | NM_001168302.2 | ENSP00000441029.1 |
Frequencies
GnomAD3 genomes AF: 0.0000980 AC: 11AN: 112191Hom.: 0 Cov.: 23 AF XY: 0.0000291 AC XY: 1AN XY: 34389
GnomAD3 genomes
AF:
AC:
11
AN:
112191
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34389
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000824 AC: 15AN: 182028Hom.: 0 AF XY: 0.0000599 AC XY: 4AN XY: 66730
GnomAD3 exomes
AF:
AC:
15
AN:
182028
Hom.:
AF XY:
AC XY:
4
AN XY:
66730
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000119 AC: 130AN: 1096780Hom.: 0 Cov.: 29 AF XY: 0.000110 AC XY: 40AN XY: 362384
GnomAD4 exome
AF:
AC:
130
AN:
1096780
Hom.:
Cov.:
29
AF XY:
AC XY:
40
AN XY:
362384
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000980 AC: 11AN: 112240Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34448
GnomAD4 genome
AF:
AC:
11
AN:
112240
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
11
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2024 | The c.1931A>G (p.E644G) alteration is located in exon 8 (coding exon 8) of the KLHL13 gene. This alteration results from a A to G substitution at nucleotide position 1931, causing the glutamic acid (E) at amino acid position 644 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;.;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D;D;D;.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;N;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N;N;N;.
REVEL
Benign
Sift
Benign
T;T;T;T;T;T;T;.
Sift4G
Benign
T;T;T;T;T;T;T;.
Polyphen
0.12, 0.45, 0.29
.;.;.;B;.;B;B;B
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at